Skip to main content
Cancer category illustration
Cancer

Prostate Cancer

VA rating criteria, C&P exam prep, evidence requirements, and secondary conditions. Free educational guide by FWD Assist HQ.

Written by Joshua Christopherson, disabled Air Force and Air National Guard veteran and VA disability claims educator.

Educational information only. FWD Assist HQ is not a law firm, medical provider, or accredited representative, and this guide is not legal, medical, or claims-representation advice. Rating criteria are summarized from 38 CFR; always confirm current rules at VA.gov and eCFR.gov.

Prostate cancer is one of the most common cancers among male veterans and is a VA presumptive condition for Agent Orange exposure. If you were exposed to Agent Orange during Vietnam-era service or in other covered locations, you do not need to prove a nexus. The VA owes you 100% while the cancer is active, and your residuals continue to be rated after treatment. Veterans who stop at service connection miss substantial compensation for what comes next.


1. What This Condition Is

Prostate cancer is a malignant tumor of the prostate gland, which sits below the bladder in men and produces seminal fluid. It is the most common cancer diagnosed among male veterans in the VA system. Early-stage prostate cancer may produce no symptoms. Advanced or treated prostate cancer frequently causes urinary dysfunction, erectile dysfunction, bowel dysfunction, pain, and fatigue.

Veterans exposed to Agent Orange (a tactical herbicide used in Vietnam and other locations) have a documented elevated risk of prostate cancer. The VA recognizes this risk by granting presumptive service connection -- meaning you do not need a nexus letter if you meet the exposure criteria. The claim still requires a current diagnosis and documentation of covered service.


2. VA Rating Criteria

Diagnostic Code: 7528 under 38 CFR 4.115b (Ratings of the Genitourinary System -- Diagnoses)

Stage Rating
Active malignancy (cancer present) 100%
Post-treatment, no evidence of recurrence or metastasis Rate residuals based on voiding dysfunction or renal dysfunction, whichever is predominant

The 100% rating continues for at least six months following any surgical intervention (such as prostatectomy) regardless of the surgical outcome. After that six-month period, or when cancer enters remission without surgery, the VA rates the remaining functional impairment. This is where most veterans lose substantial compensation.

Residuals After Treatment

Prostate cancer treatment -- whether surgery, radiation, hormone therapy, or watchful waiting -- leaves residuals that must be filed and rated separately. The two primary residual pathways are:

Voiding Dysfunction under 38 CFR 4.115a:

38 CFR 4.115a divides voiding dysfunction into three separate rating sub-categories. The VA rates the sub-category that produces the highest rating. These are not a single hierarchy -- each captures a distinct type of dysfunction.

Sub-category 1: Urine Leakage / Incontinence

Rating Criteria
60% Requires use of an appliance, or absorbent materials changed more than four times per day
40% Absorbent materials changed two to four times per day
20% Absorbent materials changed less than twice per day

Sub-category 2: Urinary Frequency

Rating Criteria
40% Daytime voiding interval less than one hour, or awakening to void five or more times per night
20% Daytime voiding interval one to two hours, or awakening to void three to four times per night
10% Daytime voiding interval two to three hours, or awakening to void two times per night

Sub-category 3: Obstructed Voiding

Rating Criteria
60% Urinary retention requiring use of a catheter device or permanent appliance
30% Urinary retention requiring intermittent or continuous catheterization

Renal Dysfunction is rated separately if kidney function is impaired by the cancer or treatment.

Agent Orange Presumptive Status

Under 38 CFR 3.307 and 3.309, prostate cancer is a presumptive condition for veterans who were exposed to Agent Orange and other tactical herbicides. Covered service includes Vietnam (January 9, 1962 to May 7, 1975), Korea (April 1, 1968 to August 31, 1971), Thailand at U.S. military bases (January 9, 1962 to June 30, 1976 under PACT Act expansion), and other qualifying locations. No nexus letter is required. You must show a diagnosis of prostate cancer and documentation of service in a covered location.


3. What to Expect at Your C&P Exam

The C&P exam for prostate cancer will review your diagnosis, treatment history, and current residuals. The examiner will assess whether the cancer is active or in remission, what treatments you received, and what functional limitations remain.

The examiner will ask: What is your current cancer status (active, in remission, recurrence)? What treatment did you receive (surgery, radiation, hormone therapy, chemotherapy)? What are your current urinary symptoms -- frequency, urgency, leakage, retention? Do you have erectile dysfunction? Do you have bowel symptoms from radiation? What is your current PSA level?

Bring your oncology records, urology notes, PSA lab results, surgical or treatment reports, and any records documenting ongoing urinary or sexual dysfunction. If you are in active treatment, focus on the 100% active rating. If you are post-treatment, focus on documenting residual symptoms in detail.


4. Evidence You Need to Win

Diagnosis: Pathology report confirming prostate adenocarcinoma (or other prostate malignancy). PSA trend records and biopsy results are standard.

Service Connection -- Agent Orange Presumptive: DD-214 or military service records documenting service in a covered location during a covered period. No nexus letter required.

Service Connection -- Standard Route (non-presumptive): A nexus letter from a physician connecting prostate cancer to a specific service exposure if Agent Orange presumptive does not apply.

DBQ Form: VA Disability Benefits Questionnaire for Male Reproductive System Conditions (Prostate Cancer). Request that the examiner complete this form specifically.

Residual Documentation: Urology notes documenting urinary frequency, incontinence, urgency, and catheter use. Records documenting erectile dysfunction. Gastroenterology or colorectal records documenting bowel dysfunction from radiation. Records of hormone therapy and its side effects.

Personal Statement: Describe your daily urinary function, pad or absorbent material usage, erectile function, and any bowel symptoms. Quantify it: how many times per night do you wake to void? How many pads per day do you use?

Buddy Statement (VA Form 21-10210): A spouse or caregiver can document your functional limitations, pad usage, and the practical impact of your residual symptoms.


5. Secondary Conditions to Consider

Erectile Dysfunction: Prostate surgery and radiation consistently cause ED. File ED as a secondary condition to prostate cancer immediately. Service-connected ED qualifies for SMC-K under 38 CFR 3.350(a) ($139.87/month in 2026) in addition to any disability rating.

Urinary Incontinence: Post-prostatectomy incontinence is one of the most common and most underrated residuals. Quantify pad usage and voiding frequency to drive the correct rating under 38 CFR 4.115a.

Bowel Dysfunction: Radiation to the prostate frequently damages the rectum and bowel, causing chronic diarrhea, urgency, bleeding, and proctitis. These can be rated as secondary conditions under digestive system diagnostic codes.

Depression and Anxiety: Cancer diagnosis and the sexual and urinary side effects of treatment cause documented depression and anxiety. Service-connected prostate cancer contributing to a depressive or anxiety disorder supports a secondary mental health claim.

Osteoporosis: Androgen deprivation therapy (hormone therapy) for prostate cancer causes bone density loss. Osteoporosis secondary to hormone therapy for service-connected prostate cancer is a ratable condition.

Peripheral Neuropathy: Chemotherapy-associated neuropathy can be rated as secondary to prostate cancer treatment under the neuropathy diagnostic codes.


6. Common Mistakes That Kill Claims

Stopping at the 100% active rating and never filing for residuals. The 100% rating drops when cancer goes into remission or six months after surgery. Veterans who do not proactively document and file for urinary dysfunction, ED, and bowel symptoms see their compensation drop dramatically. File for residuals before the 100% review.

Not knowing about Agent Orange presumptive status. Vietnam-era and Thailand-based veterans are still submitting detailed nexus letters for prostate cancer when the VA is required to grant presumptive service connection based on deployment records alone. Know which category you are in before building an evidence package.

Not filing ED as a secondary. Nearly every veteran treated for prostate cancer with surgery or radiation develops ED. This is a separate, ratable condition that qualifies for SMC-K. Filing it is straightforward and the financial impact is significant over time.

Underreporting urinary symptoms at the C&P exam. Veterans minimize symptoms at exams. If you use two pads per day and wake three times per night to urinate, say exactly that. These numbers determine your rating category under 38 CFR 4.115a.

Missing the six-month surgical rating window. The VA rates you at 100% for at least six months after prostatectomy. If your claim is not filed or decided within that window, residuals may not be evaluated in time. File the residual claim before the six-month review period ends.


7. FWD Assist Resources

These FWD Assist titles are most relevant for veterans navigating a prostate cancer claim:

  • Agent Orange VA Claims Guide -- Covers the full Agent Orange presumptive list, covered locations, and how to establish service connection without a nexus letter.
  • Secondary Conditions: How to Build a Cascading Claim -- Walks through the ED, urinary, bowel, and mental health secondaries connected to prostate cancer treatment.
  • SMC: Special Monthly Compensation Guide -- Covers SMC-K for service-connected ED following prostate cancer and other SMC levels that may apply.
  • C&P Exam Prep Guide -- Prepares you for both the initial cancer exam and the residuals exam, with guidance on documenting urinary and sexual dysfunction accurately.
  • TDIU Guide -- If prostate cancer or its residuals prevent you from maintaining substantially gainful employment, Total Disability based on Individual Unemployability may apply even before a 100% schedular rating.
  • Appeals Guide -- For veterans whose residuals were underrated or denied after the active cancer rating was reduced.

All titles are available at fwdassisthq.com.


8. Get Help Without a Claim Shark

Free, accredited help is available through VSOs including the DAV, American Legion, VFW, and AMVETS. County Veterans Service Officers assist at no cost. VA-accredited claims agents and attorneys can represent you after an initial decision.

Charging upfront fees to assist with a VA claim is illegal under 38 USC 5905. After an initial decision, accredited representatives may charge a fee capped at 20% of past-due benefits only. Do not pay anyone who asks for money before a decision is issued.

Verify accreditation at: va.gov/ogc/accreditation.asp

Get new VA claim guides by email

Free updates when new condition guides and tools drop. No spam, unsubscribe any time.

100% free, no credit card.
69 condition guides, always free to read.

--Benefits are earned through service. Filing is not taking from others -- it is claiming what is yours.

"My husband served 22 years and never filed a claim. He kept saying he did not want to take anything away from someone who needed it more. This guide helped us understand that these benefits are earned, not charity."

Michelle W.

U.S. Air Force Veteran, Spouse and Caregiver

Related Conditions in Cancer